Drug intelligence / Profile preview

TIM3-Fc

Development stage
Preclinical
Lead developer
Third Military Medical University
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Administration
Intravenous, Intraperitoneal
01

Overview

TIM3-Fc is a recombinant fusion protein consisting of the extracellular domain of T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) fused to an immunoglobulin Fc region. It acts as a decoy receptor or blocking agent for TIM-3 ligands, specifically Galectin-9. In the context of chronic graft-versus-host disease (cGVHD), TIM3-Fc disrupts the pathogenic crosstalk between Galectin-9+ senescent macrophages and TIM3+ stem-like memory CD8+ T cells (Tscm). By inhibiting this axis, it reduces the secretion of senescence-associated secretory phenotype (SASP) factors such as IL-6, IL-1β, and TGF-β, thereby ameliorating tissue fibrosis in organs like the lung and liver. The molecule is primarily used in preclinical research to investigate the role of the TIM3-Galectin9 axis in immune-mediated inflammatory and fibrotic conditions.

Other names
TIM-3-FcTIM3-FcTIM 3-FcTIM3-Fc fusion proteinTIM-3-Fc fusion proteinTIM 3-Fc fusion proteinTIM3-IgTIM-3-IgTIM 3-IgTIM-3-IgG Fc fusion proteinTIM3-IgG Fc fusion proteinTIM 3-IgG Fc fusion protein
02

Targets

HMGB1 (High mobility group protein B1)CEACAM1LGALS9 (Galectin-9)

Beyond the preview

Go deeper on TIM3-Fc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TIM3-Fc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call